Skip to content

Epidemiology and perioperative outcomes of radical cystectomy in Germany and Denmark: a population-based parallel-cohort study

Epidemiology and perioperative outcomes of radical cystectomy in Germany and Denmark: a population-based parallel-cohort study - RARC-GER-DK

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040330
Enrollment
100000
Registered
2026-07-08
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67

Interventions

Group 1: Retrospective observational cohort of adult patients aged 18 years or older who underwent radical cystectomy for urinary bladder cancer in Germany or Denmark during the study period. The expo

Sponsors

Universitätsklinikum Schleswig Holstein, Campus Kiel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients aged 18 years or older are included if they underwent radical cystectomy for urinary bladder cancer during an inpatient hospitalisation in Germany or Denmark within the defined study period. Inclusion requires a procedure code for radical cystectomy during the index hospitalisation and a primary or secondary diagnosis of urinary bladder cancer using ICD-10 C67.x. The unit of analysis is the index hospitalisation, defined as the first hospitalisation with radical cystectomy within the study period. Both patients treated with open radical cystectomy and patients treated with robotic-assisted radical cystectomy are included.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years are excluded, as are patients without a diagnosis of urinary bladder cancer using ICD-10 C67.x as a primary or secondary diagnosis. Cases with partial or simple cystectomy only, without radical cystectomy, are excluded. If more than one cystectomy occurs within the study period, only the chronologically first hospitalisation is included as the index event; subsequent cystectomy hospitalisations are excluded. Non-oncological cystectomies, for example for neurogenic bladder or trauma, are excluded through the requirement for a urinary bladder cancer diagnosis.

Design outcomes

Primary

MeasureTime frame
The primary outcome is in-hospital mortality during the index hospitalisation after radical cystectomy. The outcome is assessed for all included patients during the index hospitalisation. In Germany, in-hospital mortality is identified from the discharge disposition in the DRG microdata of the Federal Statistical Office. In Denmark, the corresponding discharge status or registry-based mortality information is used.

Secondary

MeasureTime frame
Secondary outcomes are severe perioperative events and healthcare utilisation measures during the index hospitalisation. These include a composite MACCE outcome, defined as death, myocardial infarction, stroke, acute kidney injury, sepsis, cardiopulmonary resuscitation, or unplanned reoperation, as well as the individual components of this composite outcome. Further secondary outcomes include length of hospital stay, mechanical ventilation, prolonged mechanical ventilation for more than 24 hours, intensive care unit admission, acute renal replacement therapy, temporal trends in radical cystectomy and robotic-assisted radical cystectomy, and the association between annual hospital cystectomy volume and in-hospital mortality.

Countries

Denmark, Germany

Contacts

Public ContactJakob Kohler

Universitätsklinikum Schleswig Holstein, Campus Kiel

jakob.kohler@uksh.de+4943150065337

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026